APA

Dingemanse J., Jorga K. M., Schmitt M., Gieschke R., Fotteler B., Zürcher G., Da Prada M. & van Brummelen P. (19950630). Integrated pharmacokinetics and pharmacodynamics of the novel catechol-O-methyltransferase inhibitor tolcapone during first administration to humans. : Clinical pharmacology and therapeutics.

Chicago

Dingemanse J, Jorga K M, Schmitt M, Gieschke R, Fotteler B, Zürcher G, Da Prada M and van Brummelen P. 19950630. Integrated pharmacokinetics and pharmacodynamics of the novel catechol-O-methyltransferase inhibitor tolcapone during first administration to humans. : Clinical pharmacology and therapeutics.

Harvard

Dingemanse J., Jorga K. M., Schmitt M., Gieschke R., Fotteler B., Zürcher G., Da Prada M. and van Brummelen P. (19950630). Integrated pharmacokinetics and pharmacodynamics of the novel catechol-O-methyltransferase inhibitor tolcapone during first administration to humans. : Clinical pharmacology and therapeutics.

MLA

Dingemanse J, Jorga K M, Schmitt M, Gieschke R, Fotteler B, Zürcher G, Da Prada M and van Brummelen P. Integrated pharmacokinetics and pharmacodynamics of the novel catechol-O-methyltransferase inhibitor tolcapone during first administration to humans. : Clinical pharmacology and therapeutics. 19950630.